Biogen Inc. (BIIB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 265.17 |
| Open | 265.44 |
| Bid | 264.84 x 1000 |
| Ask | 271.50 x 1400 |
| Day's range | 263.15 - 271.35 |
| 52-week range | 187.16 - 311.88 |
| Volume | |
| Avg. volume | 986,014 |
| Market cap | 38.885B |
| Beta (5Y monthly) | 0.22 |
| PE ratio (TTM) | 14.00 |
| EPS (TTM) | 19.29 |
| Earnings date | 01 May 2023 - 05 May 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 322.26 |
- Zacks
Biotech Stock Roundup: ALT Obesity Data, GILD Exercises Option, INCY Drug Approval
Incyte's (INCY) skin cancer drug approval and Altimmune's obesity data are the key highlights from the biotech sector during the past week.
- Zacks
Biogen (BIIB) Gets Positive FDA Panel Vote for Tofersen NDA
The FDA committee supports an accelerated approval of Biogen's (BIIB) tofersen for treating SOD1-ALS. The committee does not believe the data supports a traditional/standard approval for tofersen.
- Zacks
Biogen Inc. (BIIB) Stock Sinks As Market Gains: What You Should Know
Biogen Inc. (BIIB) closed the most recent trading day at $266.15, moving -0.66% from the previous trading session.
© 2023 Yahoo. All rights reserved.
